It is mandatory for medical researchers
to adhere to existing guidelines to conduct clinical trials in Brunei
The ultimate benefit of research lies not
only in the generation of new knowledge but in the translation of the
knowledge into technologies, interventions and strategies which are then
effectively and appropriately delivered to those who would benefit from
it. The Minister of Health stated this at the launch of the “Brunei
Darussalam Guidelines for Good Clinical Practice”. Pehin Dato Seri
Setia Haji Suyoi said that to reach this objective, it is imperative
that the entire research process be pursued within the context of
contemporary knowledge, good ethics, effective policy, adequate
resources and international cooperation.
Good Clinical Practice is an international
ethical and scientific quality standard for designing, conducting,
recording and reporting trials that involve the participation of human
subjects. This standard provides assurance that the data and results
are credible and accurate. It also assures that the rights, integrity
and confidentiality of trial subjects are protected. It is mandatory
for investigators to adhere to these guidelines to conduct clinical
trials in Brunei Darussalam.
A major focus of the Good Clinical Practice
guideline is to help initiate and shape the research culture in this
country to respond effectively to the needs of the government,
researchers, health professionals and the community as a whole. It will
also integrate Brunei’s current activities in research, ethics and to
regulate for better outcomes, facilitating the development of health
standards and policies. The Deputy Minister of Health, Pehin Dato
Paduka Haji Hazair was among those present. The event took place at a
hotel in the capital, Saturday.
